Tumor uptake of copper-diacetyl-bis (n4-methylthiosemicarbazone): Effect of changes in tissue oxygenation

Journal of Nuclear Medicine

Volumn 42, Issue 4, 2001, Pages 655-661

  Lewis, J S ^a   Sharp, T L ^a   Laforest, R ^a   Fujibayashi, Y ^a   Welch, M J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Copper diacetyl bis(N4 methylthiosemicarbazone); Hypoxia; Oxygen measurement

Indexed keywords

COPPER 64; COPPER DIACETYLBIS(N4 METHYLTHIOSEMICARBAZONE); HYDRALAZINE; SEMICARBAZONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; BOLUS INJECTION; CANCER MODEL; CONTROLLED STUDY; CYCLOTRON; GLIOSARCOMA; HYPOXIA; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RADIOACTIVITY; RAT; TISSUE DISTRIBUTION; TISSUE OXYGENATION; TUMOR CELL;

ANIMALS; AUTORADIOGRAPHY; COPPER RADIOISOTOPES; FEMALE; GLIOSARCOMA; HYDRALAZINE; NEOPLASM TRANSPLANTATION; ORGANOMETALLIC COMPOUNDS; OXYGEN; RADIOPHARMACEUTICALS; RATS; RATS, INBRED F344; THIOSEMICARBAZONES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0035043960     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. The hypoxic cell: A target for selective cancer therapy - Eighteenth Bruce F. Cain Memorial Award Lecture
2. The action of radium on cancer cells I. II. Some factors determining the susceptibility of cancer cells to radium
3. Concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy
4. Responses of Chinese hamster ovary cells to anticancer drugs under aerobic and hypoxic conditions
5. Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma
6. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
7. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
8. Copper-62-ATSM: A new hypoxia imaging agent with high membrane permeability and low redox potential
9. 64Cu-ATSM a hypoxia imaging agent and C-II-acetate in an acute myocardial infarction model: Ex vivo imaging in rats
10. 64Cu-ATSM in vivo in vitro in a hypoxic tumor model
11. 4-methylthiosemicarbazone): An agent for radiotherapy
12. 4-methylthiosemicarbazone) (Cu-ATSM), a hypoxia imaging agent, in canine models of ischemia
13. Quantification of Cu-ATSM kinetics by compartmental modeling in normal, ischemic and necrotic myocardium
14. Design of hypoxia-targeting radiopharmaceuticals: Selective uptake of copper-64 complexes in hypoxic cells in vitro
15. Redox-active complexes for imaging hypoxic tissues: Structure-activity relationships in copper(II)bis(thiosemicarbazone) complexes
16. Evaluation of copper-62 ATSM in patients with lung cancer as a hypoxic tissue tracer
17. Evaluation of tumor hypoxia with Cu-60-ATSM and PET
18. 60Cu]ATSM in human neoplasms
19. An approach to hypoxic PET guided conformal radiation therapy
20. 64Cu using a biomedical cyclotron
21. High purity production and potential applications of copper-60 and copper-61
22. The effect of hydralazine on the tumor cytotoxicity of the cell cytotoxin RSU 1069: Evidence for therapeutic gain
23. Hydralazine-induced tumor hypoxia: A potential target for cancer chemotherapy
24. Hydralazine enhanced selective heating of transmissible venereal tumor implants in drugs
25. Evaluation of copper(II)-pyruvaldehyde bis(N-4-methylthiosemicarbazone) for tissue blood flow measurement using a trapped tracer model
26. Fourier analysis of fluctuations of oxygen tension and blood flow in R3230Ac tumors and muscle in rats